Plasma Inflammatory Mediators Associated with Bone Metabolism in COPD

REFERENCES

• Wouters EFM. Chronic obstructive pulmonary disease: Systemic effects of COPD. Thorax 2002; 57:1067–1070.
   PubMed Web of Science ®Google Scholar
• Agusti AGN. Systemic effects of chronic obstructive pulmonary disease. Proc Amer Thorac Soc 2005; 2:367–370.
   PubMedGoogle Scholar
• Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, Wouters E, Sethi S, Cooper CB. COPD as a lung disease with systemic consequences—Clinical impact, mechanisms, and potential for early intervention. COPD 2008; 5:235–256.
   PubMedGoogle Scholar
• Ionescu AA, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J 2003; 22:64S–75.
   Web of Science ®Google Scholar
• Sin DD, Man JP, Man SF. The risk of osteoporosis in caucasian men and women with obstructive airways disease. Am J Med 2003; 114:10–14.
   PubMed Web of Science ®Google Scholar
• de Vries F, van Staa TP, Bracke MSGM, Cooper C, Leufkens HGM, Lammers JWJ. Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 2005; 25:879–884.
   PubMed Web of Science ®Google Scholar
• Jorgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: A cross sectional study. Respir Med 2007; 101:177–185.
   PubMed Web of Science ®Google Scholar
• Bolton CE, Ionescu AA, Shiels KM, Pettit RJ, Edwards PH, Stone MD, Nixon LS, Evans WD, Griffiths TL, Shale DJ. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2004; 170:1286–1293.
   PubMed Web of Science ®Google Scholar
• Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax 2004; 59:574–580.
   PubMed Web of Science ®Google Scholar
• Zhu X, Gadgil AS, Givelber R, George MP, Stoner MW, Sciurba FC, Duncan SR. Peripheral t cell functions correlate with the severity of chronic obstructive pulmonary disease. J Immunol 2009; 182:3270–3277.
   PubMed Web of Science ®Google Scholar
• Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. New Engl J Med 1995; 332:305–311.
   PubMed Web of Science ®Google Scholar
• Raisz LG. Pathogenesis of osteoporosis: Concepts, conflicts, and prospects. J Clin Invest 2005; 115:3318–3325.
   PubMed Web of Science ®Google Scholar
• Aris RM, Ontjes DA, Buell HE, Blackwood AD, Lark RK, Caminiti M, Brown SA, Renner JB, Chalermskulrat W, Lester GE. Abnormal bone turnover in cystic fibrosis adults. Osteopor Int 2002; 13:151–157.
   PubMed Web of Science ®Google Scholar
• Canalis E, Mazziotti G, Giustina A, Bilezikian J. Glucocorticoid-induced osteoporosis: Pathophysiology and therapy. Osteopor Inter 2007; 18:1319–1328.
   PubMed Web of Science ®Google Scholar
• Cortet B, Flipo RM, Pigny P, Duquesnoy B, Boersma A, Marchandise X, Delcambre B. Is bone turnover a determinant of bone mass in rheumatoid arthritis? J Rheumatol 1998; 25:2339–2344.
   PubMed Web of Science ®Google Scholar
• WHO (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva: WHO.
   Google Scholar
• Gorelik E, Landsittel DP, Marrangoni AM, Modugno F, Velikokhatnaya L, Winans MT, Bigbee WL, Herberman RB, Lokshin AE. Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol Biomarkers Prev 2005; 14:981–987.
   PubMed Web of Science ®Google Scholar
• Hirayama T, Danks L, Sabokbar A, Athanasou NA. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis. Rheumatology 2002; 41:1232– 1239.
   PubMed Web of Science ®Google Scholar
• Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: An inflammatory tale. J Clinical Invest 2006; 116:1186–1194.
   PubMed Web of Science ®Google Scholar
• Churg A, Dai J, Tai H, Xie C, Wright JL. Tumor necrosis factor-α is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 2002; 166:849–854.
   PubMed Web of Science ®Google Scholar
• Gan WQ, Man SFP, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax 2004; 59:574–580.
   PubMed Web of Science ®Google Scholar
• Mundy GR. Osteoporosis and inflammation. Nutr Rev 2007; 65:S147–151.
   PubMed Web of Science ®Google Scholar
• D'Hulst AI, Bracke KR, Maes T, De Bleecker JL, Pauwels RA, Joos GF, Brusselle GG. Role of tumour necrosis factor-α receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema. Eur Respir J 2006; 28:102–112.
   PubMed Web of Science ®Google Scholar
• Pazianas M, Rhim AD, Weinberg AM, Su C, Lichtenstein GR. The effect of anti-tnf-α therapy on spinal bone mineral density in patients with crohn's disease. Ann NY Acad Sci 2006; 1068:543–556.
   PubMed Web of Science ®Google Scholar
• Vis M, Havaardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ, Dijkmans BA, Woolf AD, Kvien TK, Lems WF. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the nfkappab ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 2006; 65:1495–1499.
   PubMed Web of Science ®Google Scholar
• Conway SP, Morton AM, Oldroyd B, Truscott JG, White H, Smith AH, Haigh I. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: Prevalence and associated factors. Thorax 2000; 55:798–804.
   PubMed Web of Science ®Google Scholar
• Ionescu AA, Nixon LS, Evans WD, Stone MD, Lewis-Jenkins V, Chatham K, Shale DJ. Bone density, body composition, and inflammatory status in cystic fibrosis. Amer J Respir Crit Care Med 2000; 162:789–794.
   PubMed Web of Science ®Google Scholar
• Aris RM, Stephens AR, Ontjes DA, Denene Blackwood A, Lark RK, Hensler MB, Neuringer IP, Lester GE. Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. Amer J Respir Crit Care Med 2000; 162:1674–1678.
   PubMed Web of Science ®Google Scholar
• Gur A, Denli A, Nas K, Cevik R, Karakoc M, Sarac AJ, Erdogan F. Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy. Rheumatol Int 2002; 22:194–198.
   PubMed Web of Science ®Google Scholar
• Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 1995; 136:3054–3061.
   PubMed Web of Science ®Google Scholar
• Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R. Estrogen deficiency induces bone loss by enhancing t-cell production of tnf-alpha. J Clin Invest 2000; 106:1229–1237.
   PubMed Web of Science ®Google Scholar
• Ruiz C, Perez E, Garcia-Martinez O, Diaz-Rodriguez L, Arroyo-Morales M, Reyes-Botella C. Expression of cytokines il-4, il-12, il-15, il-18, and ifngamma and modulation by different growth factors in cultured human osteoblast-like cells. J Bone Miner Metab 2007; 25:286–292.
   PubMed Web of Science ®Google Scholar
• Pietschmann P, Grisar J, Thien R, Willheim M, Kerschan-Schindl K, Preisinger E, Peterlik M. Immune phenotype and intracellular cytokine production of peripheral blood mononuclear cells from postmenopausal patients with osteoporotic fractures. Exper Gerontol 2001; 36:1749–1759.
   PubMed Web of Science ®Google Scholar
• Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A, Piccione E. Role of type I collagen C-telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women. J Obstet Gynaecol Res 2009; 35:152–159.
   PubMed Web of Science ®Google Scholar
• Garnero P. Biomarkers for osteoporosis management: Utility in diagnosis, fracture risk prediction and therapy monitoring y1. Mole Diagn Ther 2008; 157.
   PubMed Web of Science ®Google Scholar
• Greenspan SL, Rosen HN, Parker RA. Early changes in serum n-telopeptide and c-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women. J Clin Endocrinol Metab 2000; 85:3537–3540.
   PubMed Web of Science ®Google Scholar